These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28756843)

  • 21. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous bioprocessing: the real thing this time? 10(th) Annual bioProcessUK Conference, December 3-4, 2013, London, UK.
    Farid SS; Thompson B; Davidson A
    MAbs; 2014; 6(6):1357-61. PubMed ID: 25484060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
    J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new large-scale manufacturing platform for complex biopharmaceuticals.
    Vogel JH; Nguyen H; Giovannini R; Ignowski J; Garger S; Salgotra A; Tom J
    Biotechnol Bioeng; 2012 Dec; 109(12):3049-58. PubMed ID: 22688835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White paper on high-throughput process development for integrated continuous biomanufacturing.
    São Pedro MN; Silva TC; Patil R; Ottens M
    Biotechnol Bioeng; 2021 Sep; 118(9):3275-3286. PubMed ID: 33749840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous Manufacturing of Recombinant Therapeutic Proteins: Upstream and Downstream Technologies.
    Patil R; Walther J
    Adv Biochem Eng Biotechnol; 2018; 165():277-322. PubMed ID: 28265699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development.
    Tripathi NK; Shrivastava A
    Front Bioeng Biotechnol; 2019; 7():420. PubMed ID: 31921823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
    Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
    J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Single-use Strategy to Enable Manufacturing of Affordable Biologics.
    Jacquemart R; Vandersluis M; Zhao M; Sukhija K; Sidhu N; Stout J
    Comput Struct Biotechnol J; 2016; 14():309-18. PubMed ID: 27570613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enablers of continuous processing of biotherapeutic products.
    Rathore AS; Zydney AL; Anupa A; Nikita S; Gangwar N
    Trends Biotechnol; 2022 Jul; 40(7):804-815. PubMed ID: 35034769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanofiber adsorbents for high productivity continuous downstream processing.
    Hardick O; Dods S; Stevens B; Bracewell DG
    J Biotechnol; 2015 Nov; 213():74-82. PubMed ID: 25784156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current state of the art in continuous bioprocessing.
    Schofield M
    Biotechnol Lett; 2018 Oct; 40(9-10):1303-1309. PubMed ID: 30006662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinity Chromatography: An Enabling Technology for Large-Scale Bioprocessing.
    Łącki KM; Riske FJ
    Biotechnol J; 2020 Jan; 15(1):e1800397. PubMed ID: 31544994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies.
    Xenopoulos A
    J Biotechnol; 2015 Nov; 213():42-53. PubMed ID: 25959171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposable bioprocessing: the future has arrived.
    Rao G; Moreira A; Brorson K
    Biotechnol Bioeng; 2009 Feb; 102(2):348-56. PubMed ID: 19090536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of continuous downstream processing of monoclonal antibodies: Current trends and challenges.
    Somasundaram B; Pleitt K; Shave E; Baker K; Lua LHL
    Biotechnol Bioeng; 2018 Dec; 115(12):2893-2907. PubMed ID: 30080940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensors and chemometrics in downstream processing.
    Dürauer A; Jungbauer A; Scharl T
    Biotechnol Bioeng; 2024 Aug; 121(8):2347-2364. PubMed ID: 37470278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolving trends in mAb production processes.
    Shukla AA; Wolfe LS; Mostafa SS; Norman C
    Bioeng Transl Med; 2017 Mar; 2(1):58-69. PubMed ID: 29313024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reducing biopharmaceutical manufacturing costs through continuous processing in a flexible J.POD® facility.
    Garcia FA; Gefroh E
    Drug Discov Today; 2023 Jul; 28(7):103619. PubMed ID: 37201779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic Separation in Bioprocessing Beyond the Analytical Scale: From Biotechnology to the Food Industry.
    Schwaminger SP; Fraga-García P; Eigenfeld M; Becker TM; Berensmeier S
    Front Bioeng Biotechnol; 2019; 7():233. PubMed ID: 31612129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.